Pembrolizumab treatment increases K+ channel function and calcium fluxes in cytotoxic T cells of head and neck cancer patients

Hannah S. Newton(University of Cincinnati Medical Center), Laura Conforti(University of Cincinnati), Trisha M. Wise‐Draper(University of Cincinnati), Sarah Palackdharry(University of Cincinnati), Ameet A. Chimote(University of Cincinnati), David A. Hildeman(University of Cincinnati Medical Center), Maria Lehn(Cincinnati Children's Hospital Medical Center), Edith M. Janssen(Springhouse), Vaibhavkumar S. Gawali(University of Cincinnati)
The Journal of Immunology
May 1, 2020
Cited by 0


Related Papers